Tag Archive: SHH-MB subgroup

Aug 20 2015

Vismodegib’s Activity Tested in Medulloblastoma Subgroups

Tom Curran, PhD, FRS, of The Children’s Hospital of Philadelphia Research Institute, contributed to an article in the Journal of Clinical Oncology assessing the efficacy of a drug called vismodegib (Erivedge) in a subgroup of patients with recurrent medulloblastoma.

Permanent link to this article: http://blog.research.chop.edu/vismodegibs-activity-tested-in-medulloblastoma-subgroups/